NALOCET
Live / Registered — Registered — Section 8 accepted (as of 03 Jan 2024)
What this means for you
Registered since 25 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87502293
- Registration number
- 5571641
- Mark type
- Stylized text
- Filed
- 23 Jun 2017
- Published for opposition
- 19 Sept 2017
- Registered
- 25 Sept 2018
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of pain and inflammation
Owner
- Argent Development Group, LLC, Mountain View, CA, US
- Argent Development Group, LLC, Mountain View, CA, US
- Argent Development Group, LLC, Mountain View, CA, US
Prosecution history
- 03 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 03 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 28 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Oct 2023 — TEAS SECTION 8 RECEIVED
- 25 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Aug 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jul 2018 — USE AMENDMENT FILED
- 06 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 18 Apr 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Apr 2018 — SOU EXTENSION 1 GRANTED
- 16 Apr 2018 — SOU EXTENSION 1 FILED